奥美沙坦相关肠病：胃肠道受累的异质性 - Suppr

Suppr

超能文献

Olmesartan-associated enteropathy: heterogeneity of involvement along gastrointestinal tract.

作者信息

Dias Emanuel, Morais Rui, Gullo Irene, Lopes Pedro, Teixeira Margarida, Macedo Guilherme

机构信息

Gastroenterology Department.

Pathology Department, Centro Hospitalar de São João, Porto.

出版信息

Porto Biomed J. 2020 Sep 16;5(5):e079. doi: 10.1097/j.pbj.0000000000000079. eCollection 2020 Sep-Oct.

DOI:10.1097/j.pbj.0000000000000079

PMID:33195870

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7657573/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b7/7657573/18141d152aef/pj9-5-e079-g001.jpg

相似文献

Olmesartan-associated enteropathy: heterogeneity of involvement along gastrointestinal tract.

Porto Biomed J. 2020 Sep 16;5(5):e079. doi: 10.1097/j.pbj.0000000000000079. eCollection 2020 Sep-Oct.

"Triple Phase" Budesonide Capsules for the Treatment of Olmesartan-Induced Enteropathy.

Ann Pharmacother. 2014 Sep;48(9):1234-1237. doi: 10.1177/1060028014540608. Epub 2014 Jun 23.

Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.

Arch Pathol Lab Med. 2015 Oct;139(10):1242-7. doi: 10.5858/arpa.2015-0204-RA.

Enteropathy Associated with Olmesartan.

GE Port J Gastroenterol. 2015 Dec 3;23(2):96-100. doi: 10.1016/j.jpge.2015.10.007. eCollection 2016 Mar-Apr.

Olmesartan-associated enteropathy: results of a national survey.

Aliment Pharmacol Ther. 2014 Nov;40(9):1103-9. doi: 10.1111/apt.12937. Epub 2014 Sep 9.

Use of olmesartan and enteropathy outcomes: a multi-database study.

Aliment Pharmacol Ther. 2018 Mar;47(6):792-800. doi: 10.1111/apt.14518. Epub 2018 Jan 22.

Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.

Korean J Intern Med. 2019 Jan;34(1):90-98. doi: 10.3904/kjim.2017.002. Epub 2017 Nov 27.

[An unusual case of olmesartan induced enteropathy].

Ann Pathol. 2019 Jun;39(3):237-240. doi: 10.1016/j.annpat.2018.10.007. Epub 2019 Feb 1.

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.

PLoS One. 2015 Jun 23;10(6):e0125024. doi: 10.1371/journal.pone.0125024. eCollection 2015.

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.

Intest Res. 2017 Jul;15(3):419-421. doi: 10.5217/ir.2017.15.3.419. Epub 2017 Jun 12.

引用本文的文献

Olmesartan-Induced Ischemic Enteritis Complicated With Bowel Perforation: A Case Report and Literature Review.

Cureus. 2023 Mar 25;15(3):e36660. doi: 10.7759/cureus.36660. eCollection 2023 Mar.

Primary Localized Small Bowel Amyloidosis: A Rare Cause of Diarrhea Detected by Balloon-Assisted Enteroscopy.

Case Rep Gastroenterol. 2022 Nov 2;16(3):577-582. doi: 10.1159/000526913. eCollection 2022 Sep-Dec.

本文引用的文献

Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.

Am J Case Rep. 2019 Jan 26;20:111-116. doi: 10.12659/AJCR.913207.

Biopsies in Gastrointestinal Endoscopy: When and How.

GE Port J Gastroenterol. 2015 Sep 1;23(1):19-27. doi: 10.1016/j.jpge.2015.07.004. eCollection 2016 Jan-Feb.

Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.

Arch Pathol Lab Med. 2015 Oct;139(10):1242-7. doi: 10.5858/arpa.2015-0204-RA.

[Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].

Gastroenterol Hepatol. 2015 Oct;38(8):514-5. doi: 10.1016/j.gastrohep.2014.11.007. Epub 2014 Dec 18.

[Sprue-like enteropathy due to olmesartan: a case report].

Gastroenterol Hepatol. 2015 Feb;38(2):108-9. doi: 10.1016/j.gastrohep.2014.05.006. Epub 2014 Jun 21.

Systematic review: Sprue-like enteropathy associated with olmesartan.

Aliment Pharmacol Ther. 2014 Jul;40(1):16-23. doi: 10.1111/apt.12780. Epub 2014 May 7.

Olmesartan induced enterocolitis.

Pathology. 2014 Jun;46(4):360-1. doi: 10.1097/PAT.0000000000000104.

Severe spruelike enteropathy associated with olmesartan.

Mayo Clin Proc. 2012 Aug;87(8):732-8. doi: 10.1016/j.mayocp.2012.06.003. Epub 2012 Jun 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Olmesartan-associated enteropathy: heterogeneity of involvement along gastrointestinal tract.

Porto Biomed J. 2020 Sep 16;5(5):e079. doi: 10.1097/j.pbj.0000000000000079. eCollection 2020 Sep-Oct.

"Triple Phase" Budesonide Capsules for the Treatment of Olmesartan-Induced Enteropathy.

Ann Pharmacother. 2014 Sep;48(9):1234-1237. doi: 10.1177/1060028014540608. Epub 2014 Jun 23.

Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.

Arch Pathol Lab Med. 2015 Oct;139(10):1242-7. doi: 10.5858/arpa.2015-0204-RA.

Enteropathy Associated with Olmesartan.

GE Port J Gastroenterol. 2015 Dec 3;23(2):96-100. doi: 10.1016/j.jpge.2015.10.007. eCollection 2016 Mar-Apr.

Olmesartan-associated enteropathy: results of a national survey.

Aliment Pharmacol Ther. 2014 Nov;40(9):1103-9. doi: 10.1111/apt.12937. Epub 2014 Sep 9.

Use of olmesartan and enteropathy outcomes: a multi-database study.

Aliment Pharmacol Ther. 2018 Mar;47(6):792-800. doi: 10.1111/apt.14518. Epub 2018 Jan 22.

Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.

Korean J Intern Med. 2019 Jan;34(1):90-98. doi: 10.3904/kjim.2017.002. Epub 2017 Nov 27.

[An unusual case of olmesartan induced enteropathy].

Ann Pathol. 2019 Jun;39(3):237-240. doi: 10.1016/j.annpat.2018.10.007. Epub 2019 Feb 1.

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.

PLoS One. 2015 Jun 23;10(6):e0125024. doi: 10.1371/journal.pone.0125024. eCollection 2015.

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.

Intest Res. 2017 Jul;15(3):419-421. doi: 10.5217/ir.2017.15.3.419. Epub 2017 Jun 12.

引用本文的文献

Olmesartan-Induced Ischemic Enteritis Complicated With Bowel Perforation: A Case Report and Literature Review.

Cureus. 2023 Mar 25;15(3):e36660. doi: 10.7759/cureus.36660. eCollection 2023 Mar.

Primary Localized Small Bowel Amyloidosis: A Rare Cause of Diarrhea Detected by Balloon-Assisted Enteroscopy.

Case Rep Gastroenterol. 2022 Nov 2;16(3):577-582. doi: 10.1159/000526913. eCollection 2022 Sep-Dec.

本文引用的文献

Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.

Am J Case Rep. 2019 Jan 26;20:111-116. doi: 10.12659/AJCR.913207.

Biopsies in Gastrointestinal Endoscopy: When and How.

GE Port J Gastroenterol. 2015 Sep 1;23(1):19-27. doi: 10.1016/j.jpge.2015.07.004. eCollection 2016 Jan-Feb.

Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.

Arch Pathol Lab Med. 2015 Oct;139(10):1242-7. doi: 10.5858/arpa.2015-0204-RA.

[Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].

Gastroenterol Hepatol. 2015 Oct;38(8):514-5. doi: 10.1016/j.gastrohep.2014.11.007. Epub 2014 Dec 18.

[Sprue-like enteropathy due to olmesartan: a case report].

Gastroenterol Hepatol. 2015 Feb;38(2):108-9. doi: 10.1016/j.gastrohep.2014.05.006. Epub 2014 Jun 21.

Systematic review: Sprue-like enteropathy associated with olmesartan.

Aliment Pharmacol Ther. 2014 Jul;40(1):16-23. doi: 10.1111/apt.12780. Epub 2014 May 7.

Olmesartan induced enterocolitis.

Pathology. 2014 Jun;46(4):360-1. doi: 10.1097/PAT.0000000000000104.

Severe spruelike enteropathy associated with olmesartan.

Mayo Clin Proc. 2012 Aug;87(8):732-8. doi: 10.1016/j.mayocp.2012.06.003. Epub 2012 Jun 22.